REGISTER NOW
SUBMIT ABSTRACT
3rd World Cancer Congress - 2019
3rd World Cancer Congress - 2019 4th World Cancer Congress - 2020 | Delhi
Early Bird Registration Closes: 27th March, 2020 Abstract Submission Closes: 27th July, 2020
CONFERENCE AGENDA




DAY 2: SUNDAY, 22ND NOVEMBER, 2020


08:00 AM - 09:00 AM
REGISTRATIONS OPENS


09:00 AM - 11:00 AM
CANCER DIAGNOSTICS: FROM CUTTING EDGE TO DAILY REALITY
Earlier and better diagnosis is fundamental to achieving improved outcomes in cancer, and it is therefore heartening to witness revolutionary technological improvements in this area, including liquid biopsies, genetic testing and exciting advances in the field of imaging.
But serious challenges remains in not only bringing these breakthroughs into daily practice, but also separating hype from reality where required, understanding any necessary caveats to their application, meeting new unmet needs (e.g. patient counseling on genetic testing) and considering the challenges to existing service models (e.g. direct to consumer testing and the role of primary care in utilizing new tools for diagnosis).
The Session will focus on:
  • Cancer screening and early detection and prevention.
  • Molecular diagnostics.  Personalized genomics and clinical biomarkers.
  • Digital cancer pathology and imaging
  • Chemotherapy and biological therapeutics.
  • Innovational combinational therapies


11:00 AM - 11:10 AM
NETWORKING BREAK


11:10 AM - 01:10 PM
TRANSALATION ONCOLOGY
Translational Oncology forms the bridge between basic research and clinical practice thereby holding the key to the progress in oncology. Tumour heterogeneity, Liquid biopsies, and Immunotherapy play a vital role in Translational Oncology.
The Session will focus on:
  • Cellular and genetic oncology
  • Laboratory concepts from bench to bedside
  • Cancer microenvironment
  • Cancer trends and Opportunities
  • Radiation Oncology
  • World Cancer Market


01:10 PM - 02:00 PM
LUNCH & NETWORKING BREAK


02:00 PM - 04:00 PM
ANTI-CANCER DRUG DISCOVERY
Global Anticancer Drug market size is expected to reach USD 145.2 Billion in 2023, at a CAGR of 6.7% from 2017 to 2023. The growth of the anticancer drug market is attributed to the growing awareness towards cancer diagnosis and treatment, and increasing incidence of targeted disease(cancer, skin cancer, and oral cancer among others),coupled with increasing research and development activities.
The key players dealing in the anticancer drug market are Roche Holding Ltd, Celgene, Johnson & Johnson, Pfizer, Bristol-Myers Squibb, Novartis, AstraZeneca, Teva Pharmaceutical, Eli Lilly, Bayer, and GlaxoSmithKline among others.
This Session will focus on:
  • New Anti-Cancer Drug Development.
  • Targeted Drug Delivery.
  • Anticancer Plant-Derived Drugs.
  • Anti-Cancer Generic Medicine
  • Herbal and Traditional Anti-Cancer Medicine
  • Alternative treatments and therapeutics
  • Quality control and standardization of Anti-Cancer drug


04:00 PM - 04:20 PM
NETWORKING BREAK


04:20 PM - 05:00 PM
CULTURAL EVENTS


05:00 PM - 05:30 PM
AWARD CEREMONY & CLOSING CEREMONY


4th World Cancer Congress - 2020 | Delhi


CONTACT US


Conference Secretariat
INDIA
ARJYOPA HEALTHCARE
#2/70, Ground Floor & 1st Floor, Tanwar Colony, Motijheel, DumDum, Kolkata - 700074, WB, India
Ph: +91 7002412271
E1: [email protected]
E2: [email protected]
Whatsapp: +91 7002-412-271


UNITED STATES
ARJYOPA HEALTHCARE
16192 Coastal Hwy., Lewes, DE 19958, US
Ph: +1 (315) 543-5659
E: [email protected]


WRITE TO US
4th World Cancer Congress - 2020 | Delhi

Copyright © 2016 - [email protected]@Arjyopa Healthcare All Rights Reserved.